OSR Health, Inc. (OSRHW)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 400K 800K 1.2M Q1 '24: 910.2K Q2 '24: 881.8K Q3 '24: 823K Q4 '24: 915.3K Q1 '25: 761.3K Q2 '25: 1.1M Q3 '25: 627.7K Q4 '25: 381.3K Q1 '26: 484.1K Q2 '26: 315.7K Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Gross Profit Quarterly

0 90K 180K 270K Q1 '24: 239.8K Q2 '24: 232.3K Q3 '24: 179.1K Q4 '24: 160K Q1 '25: 168.7K Q2 '25: 32.8K Q3 '25: 261.7K Q4 '25: 129.7K Q1 '26: 160.3K Q2 '26: 86.6K Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Operating Income Quarterly

-7.5M -5M -2.5M 0 2.5M 5M 7.5M Q1 '24: -3.3M Q2 '24: -3.2M Q3 '24: -3.6M Q4 '24: -1.6M Q1 '25: -2.9M Q2 '25: -5.2M Q3 '25: -3.8M Q4 '25: -6.4M Q1 '26: -3.7M Q2 '26: -3M Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Net Income Quarterly

-12M -8M -4M 0 4M 8M 12M Q1 '22: -126 Q2 '22: -988 Q3 '22: -20K Q4 '22: -14.3K Q1 '23: 110.3K Q2 '23: 301.5K Q3 '23: 78.2K Q1 '24: -60.4K Q2 '24: -97.3K Q3 '24: -231K Q4 '24: -2M Q1 '25: -11.4M Q2 '25: -5.2M Q3 '25: -3.2M Q4 '25: -7.2M Q1 '26: -3.5M Q2 '26: -1M Q2 '22 Q1 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 400K 800K 1.2M Q1 '24: 670.4K Q2 '24: 649.5K Q3 '24: 643.9K Q4 '24: 755.2K Q1 '25: 592.6K Q2 '25: 1.1M Q3 '25: 366K Q4 '25: 251.6K Q1 '26: 323.8K Q2 '26: 229.1K Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Operating Cash Flow Quarterly

-3M -2M -1M 0 1M 2M 3M Q1 '22: -126 Q2 '22: -6.9K Q3 '22: 3.8K Q4 '22: -952 Q1 '23: -48.4K Q2 '23: -347.6K Q3 '23: -143.2K Q4 '23: -279.5K Q1 '24: -498.8K Q2 '24: -483.2K Q3 '24: -686.5K Q4 '24: -181K Q1 '25: -64.1K Q2 '25: -482.6K Q3 '25: -2.7M Q4 '25: -1.1M Q1 '26: -1M Q2 '26: -2.4M Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Quarterly

0 15M 30M 45M Q2 '22: 1.5M Q3 '22: 1.5M Q1 '23: 5.2M Q2 '23: 9.1M Q3 '23: 9.1M Q1 '24: 5.6M Q2 '24: 4.9M Q3 '24: 4M Q1 '25: 10.9M Q1 '26: 34.3M Q3 '22 Q2 '23 Q1 '24 Q3 '24 Q1 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-2.10 -1.40 -0.70 0.00 0.70 1.40 2.10 Q4 '22: -0.01 Q1 '23: 0.01 Q2 '23: 0.04 Q3 '23: 0.06 Q4 '24: -0.71 Q1 '25: -1.74 Q2 '25: -1.78 Q3 '25: -1.19 Q4 '25: -0.80 Q1 '26: 0.16 Q2 '26: 0.20 Q4 '22 Q2 '23 Q4 '24 Q2 '25 Q4 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.